The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant Award

7 Sep 2020 07:00

RNS Number : 1222Y
Byotrol PLC
07 September 2020
 

 

 

Byotrol Plc

("Byotrol" or the "Group")

 

Award of £350k grant to investigate anti-viral properties of seaweed

 

 

 

 

Byotrol plc (AIM:BYOT), the specialist infection prevention and control company, is pleased to announce that it has secured a significant grant from Innovate UK to further investigate the anti-viral properties of certain common forms of seaweed.

 

The total award is £350k over 16 months, of which £108k will be paid to Byotrol's academic partner, the Molecular Virology Research Group at the University of Liverpool, led by Professor James Stewart. The grant is specifically for research into seaweeds in sanitising products, but we believe the resulting discoveries will have significance outside of Byotrol's core markets, including potentially animal feedstuffs.

 

This grant award will help Byotrol build further on its research and development programme into developing biocides from sustainable sources. This programme, which Byotrol has been exploring for many years has demonstrated high potency anti-viral action from extracts from commonly-occurring seaweeds, the results of which have already supported a new patent filing by the Group. Byotrol expects to file further patents as the programme develops.

 

 

 

 

Trevor Francis, Chief Technology Officer of Byotrol plc commented:

 

We are delighted that Innovate UK is supporting our research into the anti-viral properties of seaweeds and we are very pleased to be working on this project with Professor James Stewart's excellent team at the University of Liverpool. It is a very exciting area of development for Byotrol.

 

 

 

 

Enquiries:

 

Byotrol plc

Trevor Francis - Chief Technology Officer

David Traynor - Chief Executive Officer

Nic Hellyer - Chief Financial Officer 01925 742 000

 

finnCap

Geoff Nash/Kate Bannatyne - Corporate Finance 020 7220 0500

Richard Chambers - ECM

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon +44 (0)207 129 1474

byotrol@flagstaffcomms.com

 

 

 

This announcement is released by Byotrol plc and, prior to publication, the information contained herein was deemed to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014. Such information is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

 

For more information, please go to byotrol.co.uk

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKQBQQBKDBCK
Date   Source Headline
29th Nov 20112:35 pmRNSHolding(s) in Company
22nd Nov 20117:00 amRNSInterim Results
14th Nov 20114:40 pmRNSHolding(s) in Company
11th Nov 20119:46 amRNSHolding(s) in Company
9th Nov 20113:30 pmRNSHolding(s) in Company
7th Nov 201110:06 amRNSResult of EGM
21st Oct 20117:00 amRNSIssue of Equity to raise £2.46m
16th Sep 20117:00 amRNSChange of Adviser
21st Jul 20114:10 pmRNSResult of AGM
20th Jul 20117:00 amRNSMulti Country Contract with Rentokil
28th Jun 20112:39 pmRNSAnnual Financial Report and AGM notice
27th Jun 201112:14 pmRNSHolding(s) in Company
24th Jun 201110:53 amRNSHolding(s) in Company
21st Jun 20117:00 amRNSPreliminary Results
11th May 20117:00 amRNSDevelopment Contract with Fortune 150 Company
7th Apr 20115:20 pmRNSHolding(s) in Company
8th Feb 20117:00 amRNSAgreement with McBride on European Licence
9th Dec 20107:00 amRNSLicence Agreement with makers of Tommee Tippee
30th Nov 20102:39 pmRNSDirector/PDMR Shareholding
16th Nov 20107:00 amRNSInterim Results
23rd Sep 20105:18 pmRNSHolding(s) in Company
3rd Sep 201010:12 amRNSHolding(s) in Company
31st Aug 201012:01 pmRNSResult of General Meeting
19th Aug 201012:50 pmRNSGrant of Options
11th Aug 20107:00 amRNSIssue of Equity
29th Jul 20103:33 pmRNSResult of AGM
7th Jul 20107:00 amRNSJDA in UK & Ireland and Agreement Extension in US
6th Jul 20102:18 pmRNSAnnual Report and Notice of AGM
30th Jun 20107:00 amRNSContract to supply Odour Elimination goods in USA
25th Jun 20103:41 pmRNSDirector/PDMR Shareholding
22nd Jun 20104:02 pmRNSDirector/PDMR Shareholding
15th Jun 20107:00 amRNS2010 Preliminary Results
28th May 20107:00 amRNSResearch Grant, Patent Grant & Directorate Change
13th Apr 20101:38 pmRNSDirector/PDMR Shareholding
13th Apr 201010:16 amRNSDirector/PDMR Shareholding
30th Mar 20102:42 pmRNSDirector/PDMR Shareholding
25th Mar 201010:00 amRNSTrading update and results date
25th Mar 201010:00 amRNSDirectorate Change
26th Feb 201012:52 pmRNSTotal Voting Rights
4th Feb 20109:42 amRNSAcquisition of ByoFresh
22nd Dec 200911:40 amRNSHolding(s) in Company
22nd Dec 200911:40 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSUS Patent and Option Agreement
1st Dec 20097:00 amRNSSociety of Food Hygiene & Technology Award
20th Nov 20097:00 amRNSDirector/PDMR Shareholding
17th Nov 20097:00 amRNSInterim Results
6th Oct 20097:00 amRNSTrading Statement
29th Sep 200911:59 amRNSHolding(s) in Company
17th Sep 20097:00 amRNSTrading Statement
11th Aug 20099:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.